KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Other Working Capital Changes: 2016-2024

Historic Other Working Capital Changes for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Dec 2024 value amounting to $959,000.

  • Amneal Pharmaceuticals' Other Working Capital Changes rose 260.32% to $10.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.1 million, marking a year-over-year increase of 274.42%. This contributed to the annual value of $959,000 for FY2024, which is 102.54% up from last year.
  • Amneal Pharmaceuticals' Other Working Capital Changes amounted to $959,000 in FY2024, which was up 102.54% from -$37.8 million recorded in FY2023.
  • In the past 5 years, Amneal Pharmaceuticals' Other Working Capital Changes ranged from a high of $22.0 million in FY2021 and a low of -$37.8 million during FY2023.
  • Moreover, its 3-year median value for Other Working Capital Changes was -$9.9 million (2022), whereas its average is -$15.6 million.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first soared by 165.99% in 2021, then plummeted by 282.66% in 2023.
  • Yearly analysis of 5 years shows Amneal Pharmaceuticals' Other Working Capital Changes stood at -$33.3 million in 2020, then spiked by 165.99% to $22.0 million in 2021, then slumped by 144.96% to -$9.9 million in 2022, then tumbled by 282.66% to -$37.8 million in 2023, then soared by 102.54% to $959,000 in 2024.